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FOREWORD
Since the advent of CSII in the management of diabetes several decades ago, the UK has seen 
a remarkable growth in the use of CSII in routine clinical management  of people with Type 1 
diabetes.  This has been largely possible due to the availability of robust technological advances 
and also evidence gathering  supporting the use of this technology for the benefit of people 
with Type 1 Diabetes. The role of CSII in the management of the sub category of people living 
with diabetes who meet the NICE guidance is now well established. At the same time we have 
seen an expansion in the availability of  CSII in the UK, it is quite comforting to know that  
most, if not all specialist diabetes teams in the UK are able to provide care to people who are 
treated with CSII. However, the data gathered through the National Diabetes Insulin Pump 
audit, clearly shows that the availability of CSII services, and the quality and outcomes of those 
using insulin pump treatment varies within UK. Clearly, further progress needs to be made in 
addressing these inequalities in the provision of CSII services in the UK.    
The availability of the current guidance produced by the “Insulin Pump Experts”  under the 
guidance of the DTN- UK represents an important first step in improving the quality of CSII 
services. This document which is  comprehensive in its scope not only provides a way forward  
for teams and clinicians in starting the CSII services in their patch but also in benchmarking 
their services so that further progress and improvements can be made, where CSII services are 
already established.
As someone who has provided CSII services in my own patch, I welcome and commend 
this excellent document.  I feel this guidance will go a long way in improving the quality of 
care we provide to people with Type 1 Diabetes, which they richly deserve and when other 
methods of treatment such as MDI have failed to achieve individualized targets and improve 
quality of life further.  
All of us, as specialists in diabetes, should thank the lead authors and the working party for 
producing this excellent document.
Dinesh Nagi 
Consultant in Diabetes & Endocrinology, The Mid Yorkshire Hospitals NHS Trust 
Chairman, Association of British Clinical Diabetologist (ABCD)
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OBJECTIVES
This guide is based on consensus from clinicians looking after more than 7000 adult insulin pump patients 
in the UK. It aims to define the requirements and principles for setting up and running a high quality and 
efficient insulin pump (CSII) service. 
Introduction 
Continuous subcutaneous insulin infusion (CSII or 
insulin pump therapy) is a mode of delivering intensive 
insulin therapy, which usually leads to improved glucose 
control and reduced hypoglycaemia. 
The indications for CSII, as recommended by NICE 
TA151, are:
Continuous subcutaneous insulin infusion (CSII or 
‘insulin pump’) therapy is recommended as a treatment 
option for adults and children 12 years and older with 
Type 1 diabetes mellitus provided that:
Attempts to achieve target haemoglobin A1c (HbA1c) 
levels with multiple daily injections (MDIs) result 
in the person experiencing disabling hypoglycaemia 
(disabling hypoglycaemia is defined as the repeated 
and unpredictable occurrence of hypoglycaemia 
that results in persistent anxiety about recurrence 
and is associated with a significant adverse effect 
on quality of life)
or
HbA1c levels have remained high (that is, at 69 
mmol/mol (8.5%) or above) on MDI therapy despite a 
high level of care.
The use of insulin pumps in the UK adult diabetes 
services ranges between 6-15% and has increased 
considerably following the introduction of the NICE 
recommendations in 2008.
What is CSII?
CSII employs a battery operated, portable, 
programmable pump to continuously deliver 
rapid-acting insulin via an infusion set inserted 
subcutaneously. The basal insulin infusion rate can be 
varied at least hourly and can be temporarily adjusted 
upwards or downwards by a fixed percentage. Several 
different basal rate profiles can be stored for use in 
different situations. Bolus doses can be given with 
meals as an immediate bolus, an extended bolus or a 
combination of the two. Most pumps incorporate bolus 
calculators which take account of insulin still active 
from previous boluses to provide advice to the user as to 
the bolus dose needed.
CSII is used as a component of self-management of 
Type 1 diabetes supported by the Diabetes Specialist 
Team. This team should at a minimum include a pump-
trained consultant diabetologist, diabetes specialist 
nurse and dietitian. 
This guide explores the service requirements of CSII 
therapy including essential and desirable service 
requirements, organisation and capacity considerations, 
pathways, programmes and data requirements. 
06 BEST PRACTICE GUIDE 
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
 - A GUIDE TO SERVICE REQUIREMENTS 
Here is a summary of the essential (E) and desirable (D) requirements for an adult insulin pump service based on 
consensus of the working group and taking into account variations in resources, skillset and staff:
INSULIN PUMP SERVICE REQUIREMENTS
Workforce (staff) requirements: 
• Dedicated consultant led multidisciplinary team trained in the use of pump therapy (E)
• Psychology link via MDT (E)
• Access to wider diabetes team e.g. podiatry, renal, ophthalmic, ante-natal services (E)
• On-going staff training in diabetes technology (E)
• Diabetes Coordinator /Technician/ Administrator (D) 
Organisation and capacity of pump service:
• 30 min follow-up, 30 - 45 min new patient appointment slots for both consultant and educator (nurse / 
dietician) led clinics
(E)
• 15 min virtual clinic slots educator (nurse / dietician) clinics (E)
• Capacity of at least 3 face-face appointments per pump user per year with extra provision for 3 virtual 
appointments per pump user per year
(E)
• Regular planned pump MDT meetings (E)
• Rapid access facility (E)
Pathway, protocols and programmes:
• Access to type 1 diabetes specific education programmes (E)
• MDT pathway for referral for consideration of pump therapy (E)
• Insulin pump initiation and follow-up protocol (E)
• Insulin pump renewal process (E)
• Access to insulin pump specific education programmes (E)
• Topic specific education groups* (D) 
• Fast track insulin pump initiation for select cases (E)
• Out of hours clinical support pathway (E)
• Peer support groups (D) 
• Protocols for in-patients (E)
Informatics and data requirements:
• Insulin pump / meter/ sensor download facility (E)
• Pre-consultation download (e.g. via Diasend / Carelink) (D) 
• Pre-consultation patient questionnaire (see online appendix) (D) 
• Database to capture clinical and pump related information (see online appendix) (E)
• Structured template for letters (see online appendix) (D) 
• IT infrastructure to enable virtual consultations (telephone, email, webcam) (E)
Consultation and support tools:
• Individual targets and holistic goals (E)
• Structured review process in clinic (see online appendix) (D) 
• Guide to downloads and reviewing downloads for people with diabetes (D) 
• Point of care HbA1c testing (D) 
Funding agreements and contractual arrangement: 
• Access to several pump types (D) 
• Funding agreements in place for all patients fulfilling NICE criteria (E)
 * Topics include exercise, carb-counting refreshers, technology updates, 
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Workforce requirements 
The core multidisciplinary team (MDT) providing the 
pump service should include pump trained:
• Consultant diabetologist
• Diabetes specialist nurse*
• Diabetes specialist dietitian*
• Access to clinical psychology services with interest 
and experience of diabetes related issues. In 
addition to direct referrals, this should include 
case-discussions with an integrated member of the 
psychology team. 
 * A diabetes educator role (trained in structured 
education and pump therapy with intensive insulin 
management skills) can be fulfilled by either a 
diabetes specialist nurse or dietician or both. The 
nurse and dietitian should ideally be trained so that 
both can function as diabetes educators and are 
competent to see pump patients independently.
There is a requirement for a wider framework of 
“pump–aware” team members who have training in the 
management of pump specific problems such as set 
failures, pump failures, in-patient and ante-natal support.
Competencies 
The pump service MDT should be formally trained 
in the use of insulin pump therapy and other 
diabetes technologies. Staff competencies need to be 
continually updated. Routine in-house pump updates 
are recommended to ensure the whole team remains 
up to date.
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Organisation
The pump service should be integrated within the wider 
type 1 diabetes service.
The following range of patient contacts need to be 
provided:
1. Face to face appointments: Attendance at consultant 
led clinics, reviews by diabetes educators (nurse/ 
dietitian) or psychologist outside these clinics.
2. Remote consultations: Usually with the diabetes 
educators via telephone, webcam appointments or 
email.
Clinic setup and structure 
There are two main clinic sub-types for face to face 
consultant led clinics. The most appropriate one 
depends on the size of the pump service, healthcare 
professional skillset and other local circumstances. 
Many services have both:
1. Dedicated consultant led multidisciplinary insulin 
pump clinic. This can include specific clinic types 
e.g. young adult pump clinic, new referrals, etc. 
2. Insulin pump patients mixed in with patients on 
MDI in specific multidisciplinary diabetes clinics e.g. 
intensive type 1 diabetes, complex diabetes, young 
adult, antenatal, etc. 
In larger centres and with the proliferation of a range 
of diabetes technologies as well as increased uptake of 
pumps, there is a shift towards insulin pump patients 
being seen in clinics with patients on MDI.  
Clinic template list size and set up
Regardless of the clinic set up and structure, the 
essential criteria detailed on page 7 need to be met. This 
includes longer appointments for pump patients. The 
consensus from across the working group is:
• 30 minutes for follow-up 
• 30-45 minutes for new patients  
The precise list size and template is dependent on 
models used for the MDT clinic detailed below. Some 
models (e.g. models 3 and 4 below) will require extra 
capacity for ad-hoc reviews by more than one MDT 
member to deliver the desired efficiencies. The clinic 
list template must also take into account time needed 
for post-clinic MDT meetings (essential requirement for 
model 2 to 5). 
Models of CSII service delivery
Having every appointment multidisciplinary is very 
resource intensive, so single clinician appointments 
should be used when appropriate. The service should 
try and use their resources appropriately to match the 
right person to the right consultation. The team must 
retain mechanisms to communicate updates on patients 
within and outside the clinic. (See next page)
ORGANISATION AND CAPACITY 
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MODEL 1 MODEL 2* MODEL 3* MODEL 4* MODEL 5*
All patients seen 
simultaneously 
in a joint MDT 
appointment 
(doctor, nurse, 
dietician)
All patients 
seen by each 
member of the 
MDT individually 
and sequentially 
in a 1-stop 
shop fashion
Patients seen by 
one or more MDT 
team members at 
each appointment 
matched 
according to need
Mixture of 
MDT and 
single clinician 
appointments
Group diabetes 
educator sessions 
with individual 
scheduled 
appointments  
 Pros • Joined up 
thinking
• MDT support 
for consultants
• Good team 
learning 
• May not require 
post clinic 
meeting
• Clearly defined 
roles for each 
MDT member
• Efficient
• Allows multiple 
short contacts 
• May allow 
second opinions 
and additional 
insights into 
care
• Enables MDT 
appointments 
and their 
advantages 
which are 
necessary for 
some patients
• Gives flexibility 
and efficiency
• Patient peer 
support  
• Effective use of 
educator team 
time
 Cons • Resource 
heavy
• Can be 
intimidating for 
the patient
• Longer visit 
time for patient 
who may feel 
overwhelmed 
by having 3 
appointments 
in 1 session
• Can result in 
unnecessary 
duplication
• Difficult to 
maintain 
relational 
continuity 
• Patient may 
not be triaged 
to appropriate 
MDT member
• Post clinic 
MDT meeting 
required 
• Patients 
need to be 
scheduled to 
the appropriate 
type of 
appointment in 
advance
• Personal 
matters 
difficult to 
discuss in 
group setting
• Not all patients 
are supportive 
of having group 
appointments
• Targeted 
reviews and 
education 
cannot be 
delivered
 Suggestions • Possibly more 
appropriate for 
teams starting 
a new pump 
service with 
small patient 
numbers
• Intra-clinic 
communication 
between team 
members 
needed to make 
this work well
• Matching 
correct MDT 
skills to correct 
patient may 
require pre-
clinic triage 
process  
• All team 
members need 
to be able 
to function 
as diabetes 
educators 
and see pump 
patients 
independently
• Relies on 
a clinic list 
template to 
support the 
above
• Group sessions 
can be used 
as an adjunct 
to shorten 
appointment 
duration in MDT 
reviews
• For reasons 
above they 
may not be a 
replacement 
for MDT 
reviews
 * Post clinic meeting and capacity for brief ‘ad-hoc’ intra-clinic reviews or discussions essential  
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All models require a joint collaborative working 
relationship between the multi-disciplinary team 
and flexibility to share or switch patients between 
individual lists. As most hospital electronic health 
record systems have not reached a maturity to 
support this set-up, for large clinics we recommend an 
administrator. This is to maintain aspects of clinical 
governance, follow-up appointment coordination, 
capturing activity, keeping patient details (e.g. pump, 
warranty status, consumables) updated etc.
 
Joint (Model 1) or Sequential (Model 2) MDT 
appointments are recommended for the following:
• New patients referred for an assessment for an 
insulin pump
• New patients already on a pump transferring from 
another centre or transitioning from a paediatric 
service
• Patients approaching 4 year warranty renewal, to 
review the appropriateness of continuing
• When considering withdrawal of pump therapy
• Where the skillset within a team is developing as in 
model 1 above.
• Hypoglycemia unawareness
• Complex cases
Virtual clinics 
Virtual clinics or remote consultations utilise 
telemedicine to deliver patient care. The benefits 
include:
• Improved engagement, quality of care and support 
to patients
• Easily accessible appointments where burden of 
travel and waiting time are reduced
• Re-inforce patient self-management and behaviour 
change by increasing patient contact and thereby 
improve quality of care and support
• Reduced overhead costs of running a clinic (e.g. does 
not require receptionist staff, pre-clinic assessments 
or clinic space)
• Potentially reduce the number of visits needed  
per year
Requirements
• Dedicated clinic space for webcam and telephone 
clinic (noise proof)
• IT set up for downloads, email and webcam clinics
• Remote downloads by patient (e.g. via Diasend, Libre 
link view, Medtronic carelink, Dexcom clarity, etc.) 
• Administrator to help with download setup, 
consistency, email administration and clinical 
governance including capturing activity for 
remuneration
• Support for documentation in letter as for face to 
face clinic contacts
• Use can be formally scheduled as part of a  
virtual telephone or skype clinic or occur 
individually as required
• Telephone or webcam consultations would 
typically take 15 mins however additional time 
for administration (e.g. time for set-up, capturing 
activity, documentation, etc.) and review of 
downloads will be required 
Job Planning
For all disciplines involved this should account for time 
spent on the following activities:
• Outpatient clinics and administration time 
• Additional or ad-hoc face to face contacts
• Virtual clinics and remote consultations including 
telephone, emails and administration time for these 
activities
• Reviewing and analysing pump and  
meter downloads
• Preparing, supporting and running patient group 
education sessions
• Clinical and service MDT meetings
• Ongoing staff training
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Capacity 
Frequency of contact
The Diabetes Control and Complications Trial has 
demonstrated that intensive therapy with regular 
contact with health care professionals can improve 
diabetes control and reduce the risk of long term 
complications (DCCT group, 1993).
The pediatric best practice tariff is based on 3 MDT 
clinics and 8 contacts per year, and the award winning 
Diabeter model from Rotterdam uses an average of 8-10 
contacts per year and achieves outstanding results. 
The mixture of face - to - face and virtual clinics can be 
individualised depending on patient needs. 
We would recommend the clinic bases capacity 
requirements on an average of 3 face - to - face 
visits per patient per year and 3 virtual or remote 
consultations per year. 
For example, patients who are well controlled and 
do not have increased care needs, an annual follow-
up may be sufficient and for those who need extra 
support more frequent follow-up and virtual support 
will be required. 
 
Using HbA1c, hypoglycaemia risk and Diabetes Distress 
scoring can help stratify those needing more support. A 
recent study from King’s College London showed that 
those with high HbA1c had higher diabetes distress. 
Allowing them more contacts was associated with 
reductions in diabetes distress as well as HbA1c. These 
patients had an average of 6 contacts (3 face to face and 
3 virtual per year) (Todd et al. 2017, Shah S et al. 2017).
In addition to this, referrals for consideration of pumps, 
pump initiation protocols, rapid reviews and fast track 
pump initiations (e.g. in pregnancy) all need to be 
factored in when planning a service. For example, in 
the first year after starting a pump, frequent contact 
and support will be required over the first few months, 
plus several virtual/remote consultations to support 
effective use of pump therapy. (See Fig 1 CSII Pathway)
Clinical MDT meetings
Clinical MDT meetings are essential for discussing cases. 
For multi-site services we recommend a single MDT to 
ensure ongoing quality improvement, accountability, 
promoting good and consistent working standards whilst 
offering high-level expertise to all patients.  For larger 
services this should be held separately to clinics with 
cases emailed to an MDT coordinator. Trainee or junior 
staff cases can be supervised by the lead clinician as part 
of routine intra or post clinic discussions and referred to 
the MDT as per criteria for discussion. 
 
Examples of patients to be discussed at the MDT meeting: 
• Discuss referrals for pump initiation
• MDT review 3-6 months after starting pump therapy
• Prior to renewal of pump warranty
• When considering withdrawal of pump therapy.
• Complex, challenging and difficult cases, problems 
or situations
• In-patient admissions and antenatal issues
• Cases requiring psychology or other MDT input
• Problematic hypoglycaemia (impaired awareness of 
hypoglycaemia or severe hypoglycaemia)
Depending on local service structures and health care 
professional  skill set, other patient groups may need 
to be included such as pre-conception, pregnancy, 
transplant.
Service development MDT meetings (specific for  
type 1 services)
Service development meetings specific to the type 1 
service should also discuss the following pump related 
service issues regularly e.g. quarterly. These should 
be held separately to clinical MDT meetings with 
involvement of service managers:
• Audit planning and reflection
• Service development
• Safety: individual patient safety concerns, device 
concerns, mortality and morbidity
• Staff development: sharing of best practice, 
guideline development, education, mentorship and 
quality assurance
012 BEST PRACTICE GUIDE 
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
 - A GUIDE TO SERVICE REQUIREMENTS 
Patient Referral
MDT Assessment
Pre-pump Education
Pump Start
Pump Start Pathway and Reviews
CLINIC
Annual Review/MDT Follow-up/
Virtual Consultations
Clinic setup and structure
Withdrawal?
Withdrawal?
Withdrawal?
Group Education Checklist
MDT Assessments
Guidance/Checklist
Funding
Documentation
Contacts
Pump specific diabetes 
education programmes
Plan capacity for 3 face-
to-face visits and 3 virtual 
or remote consultations 
per patient per year
Initiation Protocols
6/12 - Document Benefit
Group start
Group upgrade
Clinic Structure
Virtual 
Consultations
Appointment 
Types/Capacity
Protocol/Education Resources
Review checklist and 
ongoing patient safety 
MDT 
Meetings
CSII 
Database
Staff 
training and 
competencies
Figure 1: CSII Pathway
Renewal
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Access to type 1 education programmes 
This is an essential requirement for any service looking 
after people with type 1 diabetes. People with type 1 
diabetes referred for consideration of pump therapy 
must demonstrate adequate diabetes education, 
experience and understanding of functional insulin 
therapy (carbohydrate counting principles) and will 
usually have completed structured education (e.g. 
DAFNE). For those established on insulin pump therapy 
who have not had previous access to structured 
education there are pump specific courses available e.g. 
DAFNE Pump curriculum.
Insulin Pump Annual Review
Pump (and CGM) download should be reviewed, printed 
and given to the insulin pump user annually to ensure 
they have a complete record of all settings necessary 
to programme a new pump. Care processes, risk 
management and long term care planning should also 
be included. A checklist and template for annual review 
is included in the online appendix.
Out of hours support pathway 
All pump users should be educated on how to deal 
with clinical diabetes emergencies or technical pump 
problems out of hours, with written algorithms based 
on the local service model available and advice on when 
to attend the emergency department. They should be 
given emergency contact details which they should 
carry with them at all times. This should be reviewed 
and revised annually. For technical pump problems out 
of hours, patients should be advised to use the insulin 
pump manufacturers 24 hour technical support line. 
There should be a clear point of contact for any clinical 
problems during working hours. 
Some larger centres may be able to provide a 24 hour, 
7 day emergency advice service to deal with clinical 
problems and offer support out of hours. This is an 
ideal solution. It may not be feasible to offer this from a 
single centre for most services, however working with 
other local centres and a commissioning structure could 
enable this.
In-patient and emergency department support
Diabetes teams should ensure that pathways and 
algorithms are in place in emergency departments to 
manage patients on pumps presenting as emergencies 
out of hours. Regular education on this is also desirable. 
Emergency departments must have a mechanism to 
inform the diabetes team of any emergency department 
patient encounters. This will allow the diabetes team 
to contact the patient during working hours. Further 
details can be accessed from the DTN-UK guide for 
managing CSII therapy in hospitalised patients. 
When insulin pump users move location
When a pump user moves to another part of the 
country they should be encouraged to obtain 6 months 
of pump consumables prior to the move so they have 
adequate supplies while they arrange transfer to their 
new service. They should be supported to enquire with 
their pump company which services support their 
specific pump in their new locality.
PATHWAY AND PROGRAMMES 
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Data download 
Access to software and IT infrastructure to 
download and display data from pumps, glucose 
meters and CGM devices in clinic is essential. 
Pre-consultation questionnaire 
Patients should be helped to gather all the relevant 
information and be prepared for pump appointments. 
They should be set up with personal accounts for 
the data software relevant to their devices and 
advised to download their pumps and meters before 
their appointments. Ideally they should be given 
pre clinic preparation forms to complete prior to the 
appointment. This process can be done after checking 
in for clinic appointments, but experience demonstrates 
pre-appointment downloads and questionnaires lead 
to more efficient and appropriate use of clinic time 
and resources.  An example of such a questionnaire is 
available in the online appendix. 
Insulin Pump Database
A bespoke pump clinic record sheet and database is 
recommended to help structure the appointment, and 
collect the relevant information for clinical use and 
for audit. This can be set up on a hospital's existing 
diabetes database, or in an Excel spreadsheet or visual 
basic/ Microsoft access to aid data capture. Structuring 
appropriately may also allow automated flags e.g. for 
patients approaching end of their pump warranty. A 
more comprehensive database can also help business 
planning for the service. A suggested minimum dataset 
is detailed in the online appendix.
Clinic letters 
A structured clinic letter should provide a 
comprehensive up to date summary of all details about 
the pump, settings and clinical issues so that a new 
clinician unfamiliar with the patient could continue 
their care. The letter should usually be addressed to 
the patient, copy to GP and other relevant parties. 
Examples of structured letter templates are available 
in the online appendices. 
Consultation tools 
Individual targets and holistic goals should be set for 
each patient (see online appendix for goal setting tools). 
This must be accompanied with a structured review 
process in clinic and review of data downloads as 
detailed in the DTN-UK CSII best practice clinical guide.
National Insulin Pump Audit
All CSII centres in England and Wales are 
encouraged to submit data to the National Insulin 
Pump Audit which is run annually. This allows 
centres to benchmark their data and outcomes. 
INFORMATICS AND DATA REQUIREMENTS
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Competency framework for diabetes technology
The group highlighted a national need for training the 
workforce in Type 1 diabetes and diabetes technologies, 
both for established therapies such as CSII and 
continuous glucose monitoring and also emerging 
therapies, such as hybrid closed loop systems for 
example. To help support this we recommend the 
development of competency frameworks for diabetes 
technology applicable to different disciplines, grades 
and teams. Consideration should also be given to 
the concept of individual and centre accreditation 
in diabetes technology as the range and breadth of 
available devices grows. 
Minimum staffing levels 
Whilst it would be very helpful to define minimum 
staff to patient ratios to help with service planning and 
development, due to variations in clinical set up and 
job roles, precise staff to patient ratios are difficult to 
establish. A national Type 1 diabetes service audit is 
planned which should hopefully establish the national 
average staffing ratios.
The use of CSII in the UK continues to expand. Health 
care professionals involved in the care of people with 
Type 1 diabetes have a duty to ensure that their services 
support the user to optimise their chosen technology. 
Services should meet the essential requirements as 
set out in this document as well as striving to secure 
adequate capacity for their expanding CSII service. 
It is the hope of the working group that this guide 
will support teams to reflect on current practice and 
consider how they will continue to deliver care which 
best meets the needs of their CSII users.
RECOMMENDATIONS FOR FUTURE WORK
CONCLUSION
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APPENDIX
The online appendix containing useful resources for CSII services can be found at:
https://abcd.care/dtn/appendices-dtn-service-best-practice-guide 
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